On April 22, 2025, after the public announcement of the National Medical Products Administration, the Silk Fibroin Dressing (Registration Certificate Number: 20252140672) developed by Soho Biotech was approved to be listed by the NMPA, and the product was approved for the national registration certificate of Class II medical device.

Silk Fibroin Dressing

Silk fibroin Dressing, which is made of non-woven fabric impregnated with silk fibroin solution, is suitable for the coverage and care of non-chronic wounds. The launch of this product will bring more choices in the field of wound treatment, and its excellent clinical therapeutic effect will greatly improve the quality of life of patients.

Technological Advantages:

About Soho Biotech

We has undertaken the special project of National 13th Five-Year Key R&D Plan for Biomaterials Research and Development and Organ Repair Replacement, and has achieved the transformation of scientific and technological achievements in Engineering Preparation Technology and Product Development of Low Immunogenicity Collagen and Silk Fibroin. It holds core patents for silk fibroin (SFM), and has also developed various research and development technologies of new generation mainstream medical materials such as hyaluronic acid, PLA, PLLA, glucan, PCL, peptides, polyethylene, PVA, polyurethane, polytetrafluoroethylene, microcrystalline calcium, chitosan, hydroxyapatite, humanized collagen, etc.

We provides technical upgrades and new project reserves services for manufacturers and distributors, with strategic partnerships established globally with listed companies such as Fosun Pharma, Double Crane Pharma, and So-Young Group.